Metagenomic Sequencing Market Size, Share, Forecast Report 2026 to 2035
Segmentations of Metagenomic Sequencing Market :
Metagenomic Sequencing Market by Type of Offering -
- Reagents and Consumables
- Instruments
- Sequencing & Data Analytics Services
Metagenomic Sequencing Market by Type of Workflow -
- Data Processing & Analysis
- Sequencing
- Sample Processing & Library Preparation
Metagenomic Sequencing Market by Type of Technology -
- Shotgun Metagenomics Sequencing
- 16S rRNA Sequencing
- Whole Genome Sequencing & De Novo Assembly
- Metatranscriptomics
Metagenomic Sequencing Market by Application Area -
- Ecological & Environmental Metagenomics
- Clinical Diagnostics
- Drug Discovery
- Biofuel
- Industrial Applications
Metagenomic Sequencing Market by End User -
- Pharmaceutical Companies
- Research Laboratories
- Other End Users
Metagenomic Sequencing Market by Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Metagenomic Sequencing Market Snapshot
Chapter 4. Global Metagenomic Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Market Trends
4.5. Regulatory Landscape
4.6. Funding & Investment Analysis
4.7. Porter’s Five Forces Analysis
4.8. Incremental Opportunity Analysis (US$ Mn), 2025–2035
4.9. Market Penetration & Growth Prospect Mapping (US$ Mn), 2026–2035
4.10. Competitive Landscape & Market Share Analysis, 2026
4.11. Impact of AI & Bioinformatics on Metagenomic Sequencing
Chapter 5. Market Segmentation 1: By Type of Offering
5.1. Market Share, 2025 & 2035
5.2. Market Size (US$ Mn), 2022–2035
5.2.1. Reagents and Consumables
5.2.2. Instruments
5.2.3. Sequencing & Data Analytics Services
Chapter 6. Market Segmentation 2: By Type of Workflow
6.1. Market Share, 2025 & 2035
6.2. Market Size (US$ Mn), 2022–2035
6.2.1. Data Processing & Analysis
6.2.2. Sequencing
6.2.3. Sample Processing & Library Preparation
Chapter 7. Market Segmentation 3: By Type of Technology
7.1. Market Share, 2025 & 2035
7.2. Market Size (US$ Mn), 2022–2035
7.2.1. Shotgun Metagenomics Sequencing
7.2.2. 16S rRNA Sequencing
7.2.3. Whole Genome Sequencing & De Novo Assembly
7.2.4. Metatranscriptomics
Chapter 8. Market Segmentation 4: By Application Area
8.1. Market Share, 2025 & 2035
8.2. Market Size (US$ Mn), 2022–2035
8.2.1. Ecological & Environmental Metagenomics
8.2.2. Clinical Diagnostics
8.2.3. Drug Discovery
8.2.4. Biofuel
8.2.5. Industrial Applications
Chapter 9. Market Segmentation 5: By End User
9.1. Market Share, 2025 & 2035
9.2. Market Size (US$ Mn), 2022–2035
9.2.1. Pharmaceutical Companies
9.2.2. Research Laboratories
9.2.3. Other End Users
Chapter 10. Regional Market Estimates & Trend Analysis
10.1. Global Market Regional Snapshot, 2025 & 2035
10.2. North America
10.2.1. Market Revenue by Country (U.S., Canada, Mexico), 2022–2035
10.2.2. North America Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Offering, 2022–2035
10.2.3. North America Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Workflow, 2022–2035
10.2.4. North America Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Technology, 2022–2035
10.2.5. North America Metagenomic Sequencing Market Revenue (US$ Mn) By Application Area, 2022–2035
10.2.6. North America Metagenomic Sequencing Market Revenue (US$ Mn) By End User, 2022–2035
10.3. Europe
10.3.1. Market Revenue by Country, 2022–2035
10.3.2. Europe Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Offering, 2022–2035
10.3.3. Europe Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Workflow, 2022–2035
10.3.4. Europe Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Technology, 2022–2035
10.3.5. Europe Metagenomic Sequencing Market Revenue (US$ Mn) By Application Area, 2022–2035
10.3.6. Europe Metagenomic Sequencing Market Revenue (US$ Mn) By End User, 2022–2035
10.4. Asia Pacific
10.4.1. Market Revenue by Country, 2022–2035
10.4.2. Asia Pacific Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Offering, 2022–2035
10.4.3. Asia Pacific Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Workflow, 2022–2035
10.4.4. Asia Pacific Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Technology, 2022–2035
10.4.5. Asia Pacific Metagenomic Sequencing Market Revenue (US$ Mn) By Application Area, 2022–2035
10.4.6. Asia Pacific Metagenomic Sequencing Market Revenue (US$ Mn) By End User, 2022–2035
10.5. Latin America
10.5.1. Market Revenue by Country, 2022–2035
10.5.2. Latin America Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Offering, 2022–2035
10.5.3. Latin America Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Workflow, 2022–2035
10.5.4. Latin America Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Technology, 2022–2035
10.5.5. Latin America Metagenomic Sequencing Market Revenue (US$ Mn) By Application Area, 2022–2035
10.5.6. Latin America Metagenomic Sequencing Market Revenue (US$ Mn) By End User, 2022–2035
10.6. Middle East & Africa
10.6.1. Market Revenue by Country, 2022–2035
10.6.2. Middle East & Africa Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Offering, 2022–2035
10.6.3. Middle East & Africa Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Workflow, 2022–2035
10.6.4. Middle East & Africa Metagenomic Sequencing Market Revenue (US$ Mn) By Type of Technology, 2022–2035
10.6.5. Middle East & Africa Metagenomic Sequencing Market Revenue (US$ Mn) By Application Area, 2022–2035
10.6.6. Middle East & Africa Metagenomic Sequencing Market Revenue (US$ Mn) By End User, 2022–2035
Chapter 11. Competitive Landscape
11.1. Key Strategic Developments (M&A, Partnerships, Product Launches)
11.2. Market Share Analysis, 2026
11.3. Company Profiles (18 Players)
11.3.1. AstraZeneca
11.3.2. Bio-Rad
11.3.3. BGI Group
11.3.4. Eurofins Scientific
11.3.5. Hamilton Company
11.3.6. Illumina
11.3.7. Macrogen
11.3.8. NuGEN Technologies
11.3.9. Oxford Nanopore Technologies
11.3.10. PerkinElmer
11.3.11. Pacific Biosciences
11.3.12. Promega
11.3.13. PSomagen
11.3.14. QIAGEN
11.3.15. Swift Biosciences
11.3.16. Thermo Fisher Scientific
11.3.17. Zymo Research
11.3.18. Takara Bio
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Metagenomic Sequencing Market Size is valued at USD 2.53 Bn in 2025 and is predicted to reach USD 7.85 Bn by the year 2035
The Metagenomic Sequencing Market is expected to grow at a 12.4% CAGR during the forecast period for 2026 to 2035
AstraZeneca, Bio-Rad, BGI Group, Eurofins Scientific, Hamilton Company, Illumina, Macrogen, NuGEN Technologies, Oxford Nanopore Technologies, PerkinElmer, Pacific Biosciences, Promega, PSomagen, QIAGEN, Swift Biosciences, Thermo Fisher Scientific, Zymo Research, Takara Bio and Others.
Metagenomic Sequencing Market is segmented into Type of Offering, Type of Workflow, Type of Technology, Application Area, End User and Others.
North America region is leading the Metagenomic Sequencing Market.